Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.23.3
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2023
Mar. 31, 2023
Current assets    
Cash and cash equivalents $ 58,138 $ 75,058
Restricted cash 511 500
Accounts receivable, net 195,531 178,189
Prepaid expenses and other current assets 15,644 12,319
Total current assets 269,824 266,066
Property and equipment, net 44,931 39,327
Right-of-use assets 8,376 10,073
Intangible assets, net 345,392 379,632
Goodwill 408,976 561,576
Other non-current assets 13,689 9,882
TOTAL ASSETS 1,091,188 1,266,556
Current liabilities    
Accounts payable 139,852 119,338
Accrued revenue share 55,149 69,221
Accrued compensation 8,627 10,984
Other current liabilities 41,219 21,377
Total current liabilities 244,847 220,920
Long-term debt, net of debt issuance costs 383,810 410,522
Deferred tax liabilities, net 2,816 13,940
Other non-current liabilities 11,853 13,919
Total liabilities 643,326 659,301
Commitments and contingencies
Stockholders’ equity    
Preferred stock 100 100
Common stock 10 10
Additional paid-in capital 842,677 822,217
Treasury stock (758,125 shares at September 30, 2023, and March 31, 2023) (71) (71)
Accumulated other comprehensive loss (50,078) (41,945)
Accumulated deficit (344,776) (175,115)
Total stockholders’ equity 447,862 605,196
Non-controlling interest 0 2,059
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY $ 1,091,188 $ 1,266,556